BAM
JNJ icon

Brave Asset Management’s Johnson & Johnson JNJ Stock Holding History

Brave Asset Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Sell
8,712
-655
-7% -$153K 0.47% 25
2026
Q1 		$2.29M Sell
9,367
-110
-1% -$25.6K 0.54% 25
2025
Q4 		$1.96M Sell
9,477
-20
-0.2% -$3.96K 0.46% 26
2025
Q3 		$1.76M Sell
9,497
-15
-0.2% -$2.57K 0.43% 28
2025
Q2 		$1.45M Hold
9,512
– – 0.39% 33
2025
Q1 		$1.58M Hold
9,512
– – 0.49% 32
2024
Q4 		$1.38M Sell
9,512
-578
-6% -$89.6K 0.44% 32
2024
Q3 		$1.64M Hold
10,090
– – 0.4% 31
2024
Q2 		$1.47M Buy
10,090
+402
+4% +$59.8K 0.38% 30
2024
Q1 		$1.53M Buy
9,688
+1,928
+25% +$307K 0.4% 28
2023
Q4 		$1.22M Sell
7,760
-70
-0.9% -$10.7K 0.34% 30
2023
Q3 		$1.22M Sell
7,830
-150
-2% -$24.8K 0.37% 29
2023
Q2 		$1.32M Hold
7,980
– – 0.39% 27
2023
Q1 		$1.24M Buy
7,980
+150
+2% +$24.2K 0.39% 29
2022
Q4 		$1.38M Hold
7,830
– – 0.47% 26
2022
Q3 		$1.28M Hold
7,830
– – 0.65% 23
2022
Q2 		$1.39M Buy
7,830
+120
+2% +$21.4K 0.62% 25
2022
Q1 		$1.37M Buy
7,710
+1,494
+24% +$254K 0.47% 32
2021
Q4 		$1.06M Sell
6,216
-122
-2% -$20K 0.29% 40
2021
Q3 		$1.02M Buy
6,338
+21
+0.3% +$3.58K 0.3% 44
2021
Q2 		$1.04M Buy
6,317
+12
+0.2% +$1.99K 0.31% 45
2021
Q1 		$1.04M Hold
6,305
– – 0.35% 44
2020
Q4 		$992K Sell
6,305
-60
-0.9% -$8.85K 0.38% 45
2020
Q3 		$948K Hold
6,365
– – 0.45% 35
2020
Q2 		$895K Sell
6,365
-13
-0.2% -$1.89K 0.47% 35
2020
Q1 		$836K Hold
6,378
– – 0.52% 37
2019
Q4 		$930K Sell
6,378
-4,098
-39% -$556K 0.48% 46
2019
Q3 		$1.35M Sell
10,476
-200
-2% -$26.3K 0.78% 32
2019
Q2 		$1.49M Sell
10,676
-3,433
-24% -$475K 0.83% 30
2019
Q1 		$1.97M Sell
14,109
-85
-0.6% -$11.4K 1.1% 28
2018
Q4 		$1.83M Sell
14,194
-1,509
-10% -$210K 1.23% 28
2018
Q3 		$2.17M Hold
15,703
– – 1.11% 30
2018
Q2 		$1.91M Hold
15,703
– – 1.11% 34
2018
Q1 		$2.01M Sell
15,703
-600
-4% -$81.1K 1.21% 30
2017
Q4 		$2.28M Sell
16,303
-340
-2% -$47.4K 1.19% 22
2017
Q3 		$2.16M Sell
16,643
-1,400
-8% -$186K 1.14% 21
2017
Q2 		$2.39M Sell
18,043
-100
-0.6% -$12.8K 1.27% 20
2017
Q1 		$2.26M Sell
18,143
-4,113
-18% -$491K 1.32% 20
2016
Q4 		$2.56M Sell
22,256
-100
-0.4% -$11.6K 1.64% 14
2016
Q3 		$2.64M Sell
22,356
-720
-3% -$87.3K 1.69% 12
2016
Q2 		$2.8M Hold
23,076
– – 1.87% 10
2016
Q1 		$2.5M Sell
23,076
-4,650
-17% -$481K 1.75% 13
2015
Q4 		$2.85M Hold
27,726
– – 1.93% 6
2015
Q3 		$2.59M Buy
27,726
+3,200
+13% +$310K 1.98% 9
2015
Q2 		$2.39M Buy
24,526
+500
+2% +$50.1K 1.67% 12
2015
Q1 		$2.42M Sell
24,026
-100
-0.4% -$10.2K 1.69% 13
2014
Q4 		$2.52M Buy
24,126
+10
+0% +$1.05K 1.81% 10
2014
Q3 		$2.57M Hold
24,116
– – 1.91% 8
2014
Q2 		$2.52M Hold
24,116
– – 1.78% 9
2014
Q1 		$2.37M Sell
24,116
-235
-1% -$21.8K 1.88% 9
2013
Q4 		$2.23M Buy
+24,351
New +$2.24M 1.78% 10

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Brave Asset Management's JNJ Position: Q2 2026 in Review

Brave Asset Management reduced its Johnson & Johnson (JNJ) stake by 7% in Q2 2026, selling an estimated $153K and leaving 8,712 shares worth $2.21M. The position accounts for 0.47% of the portfolio, ranked #25.

Brave Asset Management first reported a position in JNJ in Q4 2013 and has held it in 51 quarters since. The position peaked at $2.85M in Q4 2015. 2,377 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Brave Asset Management held 8,712 shares of Johnson & Johnson worth $2.21M as of Q2 2026.
  • Brave Asset Management sold 655 Johnson & Johnson shares in Q2 2026, an estimated $153K.
  • Johnson & Johnson made up 0.47% of Brave Asset Management's portfolio in Q2 2026, its #25 holding.
  • Brave Asset Management first reported a position in Johnson & Johnson in Q4 2013 and has held it in 51 quarters since.
  • Brave Asset Management's Johnson & Johnson position peaked at $2.85M in Q4 2015.
  • 2,377 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Brave Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.